Links from this page to related variants, conditions, drugs and topics are not included for automated readers. Those connections are the Gene Knowledge Graph and are licensed as data: https://www.mygenelog.com/license

Standard

Plateletcrit

ZFPM1 · rs59865663

Strength of the evidence

1 / 4

Its strongest genetic-study result is p = 10−19, with 3 associations in the GWAS Catalog.

How this is scored

4: ClinVar disease-causing, reviewed by an expert panel or a guideline (3–4 stars). 3: ClinVar, several labs agreeing (2 stars), or a genetic study at p ≤ 10−50. 2: ClinVar from one lab (1 star), or p ≤ 10−20. 1: ClinVar submitted without criteria (0 stars), or genome-wide significance (p ≤ 5×10−8). The higher of the two counts. It says how solid the evidence is, not whether it matters for a particular person.

What the study found

Who was studied 164,339 European ancestry individuals.

The effect Each copy of the A allele shifted the measure 0.0419 higher (95% confidence interval 0.033-0.051); p = 1 × 10−19.

How common The A allele had a frequency of about 20% in the people studied.

Where it sits Chromosome 16, band 16q24.2 — in an intron of ZFPM1.

How common each version is

AG
Korean KRGDB
A 30.9% · G 69.2%
Korean Korea4K
A 29.2% · G 70.8%
Korean Korea1K
A 29.5% · G 70.5%
Japanese ToMMo
A 32.7% · G 67.3%
Vietnamese
A 25.7% · G 74.3%
World gnomAD
A 16.6% · G 83.4%
World 1000 Genomes
A 16.1% · G 83.9%
World TOPMed
A 16.5% · G 83.5%

By ancestry gnomAD

East Asian
A 27.1% · G 72.9%
European (non-Finnish)
A 20.5% · G 79.5%
African / African American
A 6.9% · G 93.1%
South Asian
A 13.1% · G 86.9%
Admixed American (Latino)
A 18.6% · G 81.4%
Middle Eastern
A 23.1% · G 76.9%
Finnish
A 19.9% · G 80.1%
Ashkenazi Jewish
A 28.3% · G 71.7%

The share of all copies of this position that are each version. Source: the population studies published in dbSNP (US NCBI); each row names its study. The ancestry rows are gnomAD's own groups (via Ensembl), as the survey defines them, not races.

What each result means

A/A Two copies of the version the research linked to Plateletcrit. That is the strongest link of the three results. A link in a study is not a diagnosis.
A/G One copy of the version the research linked to Plateletcrit. That is a smaller link than two copies.
G/G No copy of the version the research linked to Plateletcrit. This is the starting point the study compared everyone against.
Source

Quoting this page

Licensed CC BY-NC 4.0: free to read, share and adapt for non-commercial use, naming MyGeneLog™ and linking the exact page. Commercial use, including training or serving a commercial AI system, needs a licence — https://www.mygenelog.com/license

Plateletcrit (rs59865663). MyGeneLog™. https://www.mygenelog.com/variants/rs59865663

← See all variants